Log In
BCIQ
Print this Print this
 

PneumomAb

  Manage Alerts
Collapse Summary General Information
Company Pamlico BioPharma Inc.
DescriptionMixture of serotype-specific human mAbs against Streptococcus pneumoniae (SPN)
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationStreptococcus
Indication DetailsTreat severe community-acquired pneumococcal pneumonia caused by caused by Streptococcus pneumoniae
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today